CTOS 2021 - The 2021 Annual Meeting Connective Tissue Oncology Society
Nov 10 - Nov 13, 2021 | VancouverCanada
LARVOL is not affiliated with The 2021 Annual Meeting Connective Tissue Oncology Society and all trademarks, logos, and brand names are property of their respective owners
Showing 75 abstracts linked to Trials
SPEARHEAD-1: A PHASE 2 TRIAL OF AFAMITRESGENE AUTOLEUCEL (FORMERLY ADP-A2M4) IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA
SAFETY AND EFFICACY OF THE TETRAVALENT DEATH RECEPTOR 5 AGONIST INBRX-109 IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA: UPDATE FROM THE PHASE 1 EXPANSION COHORT
PHASE II STUDY OF ERIBULIN AND PEMBROLIZUMAB IN PATIENTS WITH METASTATIC SOFT TISSUE SARCOMA
PROSPECTIVE SINGLE-ARM CONTROLLED TRIAL OF 3-WEEK-COURSE HYPOFRACTIONATED PREOPERATIVE RADIOTHERAPY FOR SOFT TISSUE SARCOMA OF THE EXTREMITY OR TRUNK
METRONOMIC SIROLIMUS AND CYCLOPHOSPHAMIDE IN METASTATIC OR UNRESECTABLE CHONDROSARCOMA; RESULTS OF THE COSYMO PHASE II TRIAL
A PHASE IA/IB DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2-P53 ANTAGONIST BI 907828 IN PATIENTS WITH ADVANCED/METASTATIC SARCOMA
PHASE I TRIAL OF OLARATUMAB PLUS TRABECTEDIN IN ADVANCED SOFT-TISSUE SARCOMA PATIENTS: OLATRASTS, A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY
DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: ANALYSIS FROM SCOUT TRIAL
TENOSYNOVIAL GIANT CELL TUMOR OBSERVATIONAL PLATFORM PROJECT (TOPP): 2-YEAR OBSERVATIONAL ANALYSIS OF PATIENT-REPORTED OUTCOMES BASED ON TREATMENT STRATEGIES FROM AN EU/US PROSPECTIVE REGISTRY
TK216 FOR EWING SARCOMA- INTERIM PHASE 1/2 RESULTS
FINAL ANALYSIS FROM AMPECT, AN OPEN-LABEL PHASE 2 REGISTRATION TRIAL OF NAB-SIROLIMUS FOR PATIENTS WITH ADVANCED MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMORS (PECOMA)
A PHASE 2 STUDY OF TALIMOGENE LAHERPAREPVEC, NIVOLUMAB AND TRABECTEDIN (TNT) IN ADVANCED SARCOMA
IMMUNE INFILTRATE IN PRIMARY HIGH-RISK SOFT TISSUE SARCOMAS TREATED WITH NEOADJUVANT CHEMOTHERAPY AND SURGERY IN THE ISG-STS-1001 RANDOMISED TRIAL: A PROGNOSTIC STUDY
HEALTH-RELATED QUALITY OF LIFE PREDICTS 1-YEAR-SURVIVAL IN SARCOMA PATIENTS - RESULTS OF A GERMAN OBSERVATIONAL STUDY
A RANDOMIZED PHASE 2 STUDY OF NIVOLUMAB MONOTHERAPY OR NIVOLUMAB COMBINED WITH IPILIMUMAB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS